Andrea Denker is Professor of "Accelerator Physics for Medicine"

Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB.

Prof. Dr. Andrea Denker is the head of the department "Proton Therapy" at HZB. © HZB/ M. Setzpfandt

The Beuth Hochschule für Technik Berlin and the Helmholtz-Zentrum Berlin (HZB) have appointed Prof. Dr. Andrea Denker to the joint professorship "Accelerator Physics for Medicine" as of October 1, 2018. Since 2006, Andrea Denker is head of the department "Proton Therapy" at the HZB, which operates the accelerator for eye tumor therapy. The therapy, offered in cooperation with the Charité - Universitätsmedizin Berlin and the HZB, is unique in Germany.

As part of her professorship, Andrea Denker is taking on lectures in the "Physical Technology - Medical Physics" course at Beuth University. In the current winter semester she offers the lecture "Atomic and Nuclear Physics" for Bachelor students.

Even before her appointment, Andrea Denker was a lecturer at the university. "I enjoy this job very much and the contact with the students is very enriching for me and my team at HZB," says Denker. The appointment now creates an even closer connection to the university. "We are already looking forward to many interesting theses that will be written at the proton accelerator at the HZB.

Andrea Denker studied and received her doctorate in physics at the University of Stuttgart. Then she worked at the CSNSM (Centre de Sciences Nucléaires et de Sciences de la Matière) in Orsay, France. In 1995 Andrea Denker started as a scientist at the ion accelerator ISL. Among other things, she calculated and developed the beam parameters for eye tumor therapy, which was launched 20 years ago.


You might also be interested in

  • Tiburtius Prize for Eike Köhnen
    Tiburtius Prize for Eike Köhnen
    On Tuesday, 6 December 2022, Dr. Eike Köhnen received the Tiburtius Prize (First Place) for outstanding dissertations. Eike Köhnen has contributed to significantly increasing the efficiency of tandem solar cells made of perovskite and silicon, to the point of setting world records.
  • Two women, one mission: living diversity at HZB
    Two women, one mission: living diversity at HZB
    At the end of October 2022, the management appointed Ana Sofia Anselmo and Silvia Zerbe as new diversity officers. Together they will address diversity at HZB and drive it forward with employees. Ana works in the Director’s Office and is responsible for International Affairs. Silvia is deputy press spokesperson at HZB and is dedicated to internal communication at the centre.

  • Nanodiamonds can be activated as photocatalysts with sunlight
    Science Highlight
    Nanodiamonds can be activated as photocatalysts with sunlight
    Nanodiamond materials have potential as low-cost photocatalysts. But until now, such carbon nanoparticles required high-energy UV light to become active. The DIACAT consortium has therefore produced and analysed variations of nanodiamond materials. The work shows: If the surface of the nanoparticles is occupied by sufficient hydrogen atoms, even the weaker energy of blue sunlight is sufficient for excitation. Future photocatalysts based on nanodiamonds might be able to convert CO2 or N2 into hydrocarbons or ammonia with sunlight.